© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 3.82% of ARMP shares are held by financial institutions. QUBE RESEARCH & TECHNOLOGIES LTD is the top corporate investor, holding 22.41K shares valued at $93.69K. A 0.06% stake in Armata Pharmaceuticals, Inc. is owned by the company. BLACKROCK INC. owns 23.87K shares valued at $99.77K, which translates its holding of 0.07% of the stake in the company.
Among the ARMP insiders holding of 70.25% of the stake in company, BIOGEN IDEC INC, 10 percent owner, holds the largest shares of 11.7M. INNOVIVA STRATEGIC OPPORTUNITIES LLC, , is the second largest ARMP insider with ownership of 2.69M shares. KIRK RANDAL J, 10 percent owner, stands third with possession of 674.17K shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ARMP shares is 25, representing 3.82% of the company's common stock.
QUBE RESEARCH & TECHNOLOGIES LTD, in the last quarter, reduced its stake in ARMP by -4.88% restricting it's holding to 22.41 thousand shares of worth nearly $93.69K. TEAM FINANCIAL GROUP, LLC also lessened -100% of the ARMP shares from its portfolio, reducing its holding to 0 shares of worth -. TENNESSEE VALLEY ASSET MANAGEMENT PARTNERS also shunned ARMP shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, BLACKROCK INC. increased its stake in ARMP by 4.87% in the last quarter. The institutional holder raised its holding to 23.87 thousand shares having worth more than $99.77K. SEACREST WEALTH MANAGEMENT, LLC also added 80.79% more shares of ARMP to its portfolio, raising its holding to 32.78 thousand shares of worth $137.01K. CITADEL ADVISORS LLC also increased its ARMP shares holding by 100% which brought its holding to 200 shares worth $836.00.
The insider with the most stakes in ARMP is BIOGEN IDEC INC , 10 percent owner at the company. Additionally, ARMP stock is highly held by Innoviva Strategic Opportunities LLC and 10 percent owner KIRK RANDAL J among others.
Company executives, directors, and other insiders own 70.25% percent of Armata Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which ARMP insiders have sold stock, totaling 0 shares. Insiders that have sold shares include KIRK RANDAL J, MARXE AUSTIN W & GREENHOUSE DAVID M, and BIOGEN IDEC INC.
There have been 0 transaction(s) during the past 6-months in which Armata Pharmaceuticals, Inc. insiders have bought stock, totalling 0 shares
Around 0 Armata Pharmaceuticals, Inc. shares are held by insiders, which represents about 70.25% of ARMP stock.
ARMP 10 percent owner, BIOGEN IDEC INC holds the largest portfolio of the company's shares. ARMP shares owned by BIOGEN total nearly 11.7 million.
QUBE RESEARCH & TECHNOLOGIES LTD is the largest institutional owner in ARMP which holds 22.41 thousand shares worth $93.69K or 0.06% of the total ARMP shares outstanding followed by BLACKROCK INC. with ownership of 23.87 thousand shares representing 0.07% of the ARMP ownership. SEACREST WEALTH MANAGEMENT, LLC is the third largest stakeholder with 32.78 thousand shares or 0.09% of the ownership worth more than $137.01K.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ARMP is concerned, it is a stock which is optionable.
Number of ARMP shares short is 4.54K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 36.18M shares of ARMP are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ARMP has 11.04M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ARMP is 0.86.